Get the latest QGEN - Qiagen N.V. stock market performance data and financial news.
Get the latest QGEN - Qiagen N.V. together with stock market performance data and financial news.
Read Jim Cramer's take on Qiagen N.V. (QGEN) and get his latest thoughts on the company?s performance and outlook
Get the latest QGEN - Qiagen N.V. stock market performance data and financial news.
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
The Dutch molecular diagnostic company will pay $1.6 billion for its U.S. rival.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10360441/1/qiagen-inks-deal-for-digene.html
The companies that supply the tools needed for pharma research and development often profit no matter the success of a drug trial.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10410428/1/the-real-winners-of-drug-experimentation.html
Qiagen rises on a licensing deal with Germany's Epigenomics.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10359384/1/tuesdays-health-winners-losers.html
Cholestech and Digene soar on respective merger news.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10360514/1/mondays-health-winners-losers.html
FDA approves 2 genetic tests from Hologic to assess the risks of cervical cancer. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10472074/1/fda-approves-2-new-hpv-tests-from-hologic.html
Connect with TheStreet